Phospho-ß-Catenin (Ser33/37/Thr41) Antibody for Western Blotting

Biochemistry
Stanford University
Senior Research Scientist

Overall

Quality of Results

Ease-of-Optimization

What do these ratings mean?
Write a Review

Company:

Cell Signaling Technology

Product Name:

Phospho-β-Catenin (Ser33/37/Thr41) Antibody

Catalog Number:

9561

The WNT pathway is essential for embryonic development and adult tissue homeostasis. Deregulation of this pathway results in cancers of the stomach, intestine, breast, etc. I am interested in studying the molecular mechanism of oncogenic WNT signal transduction to identify potential targets for therapeutic intervention of colon cancer. The goal of this experiment is to determine good working antibodies for the purpose of blotting some of the core components of the WNT pathway. This antibody is a bit weak and has a few non-specific bands but overall works well for western blotting.

Experimental Design and Results Summary

Applications

Western Blot

Sample

RKO (whole-cell extract)

Primary Incubation

1:1000 dilution in 1xTBS-T; overnight at 4°C for 16 hr

Blocking Agent

5% BSA in TBS-T

Secondary Incubation

1:10,000 dilution of donkey anti-rabbit IgG+HRP; 1 hr at room temperature

Tertiary Incubation

None

Detection

ECL pico

Results Summary

This antibody detects beta-catenin when phosphorylated at Ser33/Ser37/Thr41 by GSK3beta. WNT3A treatment for 4 hours results in elevation of beta-catenin levels and a significant portion of this elevated pool is still phosphorylated at these sites by GSK3beta sites (feedback mechanism to maintain steady-state beta-catenin levels in cells).

DOI or PMID #

N/A

Additional Notes

N/A

Image Gallery

Summary

The Good

Signal is a bit weak but can be improved by treating the cells with proteasome inhibitor.

The Bad

A few non-specific bands

The Bottom Line

Works well for Western Blotting

Share your experience with other scientists. Write a Review! »

Join the discussion